Status:
COMPLETED
Outcome of Multimodal Anesthesia Bern
Lead Sponsor:
Insel Gruppe AG, University Hospital Bern
Conditions:
Opioid Use
Pain, Postoperative
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
In the context of the ongoing opioid crisis in the USA and Europe, reducing perioperative opioid use is a growing priority. Multimodal anesthesia (MMA) offers a patient-centered alternative to opioid-...
Eligibility Criteria
Inclusion
- Existing informed consent
- German, Italian or French speaking
- Age 18 or more
- Planned duration of surgery 60min or more
- Inpatients and postoperative transfer to PACU or 24h ICU
Exclusion
- Palliative or emergency procedures
- Reoperation (e.g. 2nd look)
- Bariatric surgery patients
- Pregnancy / breastfeeding
- Adults legally protected
- Known allergy or contraindication to interventional medication
Key Trial Info
Start Date :
June 16 2025
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 18 2025
Estimated Enrollment :
240 Patients enrolled
Trial Details
Trial ID
NCT06985069
Start Date
June 16 2025
End Date
September 18 2025
Last Update
November 18 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Anaesthesiology and Pain Medicine, Inselspital, Bern University Hospital
Bern, Switzerland, 3010